In October 2008, Community Health Plan of Washington put a new piece of software to work. The revealing result was something that stopped happening: different departments stopped conducting duplicate assessments of the same patients. Utilization management, disease management, and case management could see information together. A member’s story no longer needed quite so many retellings.
- Jiva connects care management, authorizations, analytics, and workflows.
- Its buyers are health plans and organizations responsible for care costs.
- The practical lesson: measure the handoff, then fund the work of fixing it.
That small administrative change explains a great deal about ZeOmega. Healthcare’s coordination problems can sound abstract until somebody has to repeat an assessment, chase a discharge notification, or switch applications to finish one task. The company sells software for precisely those moments. Its central proposition is that information becomes more useful when it reaches the next person with a clear next step.
A company built between systems
Founder Sam Rangaswamy came to the problem with an interesting apprenticeship. Before starting ZeOmega in 2001, he worked on web solutions for American Airlines and the Sabre Group. He also developed automated fax and web preauthorization tools at a medical-management startup, using decision-tree algorithms. Today’s arguments about intelligent authorization have a surprisingly long prehistory.
Jiva, the company’s healthcare enterprise management platform, brings care management, utilization management, clinical content, analytics, and configurable rules into one environment. Care management organizes support for members. Utilization management addresses whether requested services meet coverage and clinical requirements. Those activities overlap in real life; separate applications can make the overlap somebody else’s clerical problem.
The buyers include commercial insurers, Medicare Advantage and Medicaid plans, health systems, and accountable care organizations. They share responsibility for populations and budgets. A hospital chart records an encounter. Jiva helps organizations coordinate work around members across encounters, departments, and systems. That places ZeOmega in the payer and population-health software market, alongside HealthEdge GuidingCare, Zyter TruCare, MHK CareProminence, and VirtualHealth HELIOS.
The business followed the money at risk. In 2013, ZeOmega raised $21.5 million in a round led by Bregal Sagemount, with BlueCross BlueShield Venture Partners and Sandbox Industries participating. Co-founder and then-CFO Nandini Rangaswamy explained that providers taking on financial accountability needed more technology. The funding was intended for infrastructure and hiring as the company expanded beyond its payer base.
The price of connecting the dots
Enterprise software arrives with enterprise economics. In June 2026, Inland Empire Health Plan staff proposed a Jiva program costing up to $20 million over five years, including outside implementation support. The estimates included $5.1 million for one-time implementation and $2.98 million in annual platform licensing. Keeping the existing system was estimated to require $18.8 million in upgrades and ongoing expenses.
Five-year ceiling for Jiva and implementation support
The attraction lay in changing operations: staff projected $14 million to $18 million in reduced inefficiencies over five years. Those were forecasts, not banked savings. The proposal also funded people to map workflows, test systems, and train colleagues. Anyone buying a similar platform can copy that budgeting habit. The subscription is only part of the job.
Ten days. Then three.
Prior authorization makes the handoff especially visible. A provider requests approval; the payer needs information, applies criteria, and returns a decision. ZeOmega’s HealthUnity Smart Authorization Gateway uses FHIR, a healthcare data-exchange standard, to connect that process with providers’ electronic records. Its Smart UM suite also includes fax processing, medical-policy digitization, and tools to assist clinical review.
Smart Auth Optimizer, launched in August 2025, adds machine learning to identify requests suitable for automated approval. ZeOmega reports that one unnamed health plan reduced authorization turnaround from ten days to three within seven months. The company also projected a 9% reduction in annual utilization-management operating expenses. The distinction matters: the turnaround result was reported as achieved; the spending reduction was projected.
This is not a universal performance promise. Deployment involves tuning a model to customer data, configuring rules, and monitoring results. The product includes fairness checks and model-performance monitoring; the broader suite describes human oversight. A health plan with unreliable data or poorly maintained policies still has work to do before automation deserves its confidence.
The next step needs an owner
ZeOmega’s partnerships extend the same logic. Its Microsoft Cloud for Healthcare integration brings social-needs information into care workflows. Population Health Navigator, announced with MedeAnalytics in July 2025, connects predictive analytics with care coordination. Social Care Connect addresses closed-loop referrals. Spotting a transportation problem helps only if somebody can arrange transportation and establish whether the referral worked.
“Jiva is our entire clinical workflow.”Anonymous manager, September 2026
Customer feedback published by ZeOmega
Quality teams get their own version of the handoff. Jiva Care Quality Navigator centralizes HEDIS and CMS Stars program data, with workflows intended to help close care gaps. A score can tell an organization where it stands. The operational challenge is reaching the right member, arranging the missing service, and bringing the result back into the system. That is where analytics has to become someone’s task.
There is external recognition: Jiva won the KLAS payer care-management category in 2022 through 2025. In the 2025 table, it scored 82.2 out of 100 across 21 organizations. These are customer-experience measures, not clinical trial results. ZeOmega subsequently announced DirectTrust AI Accreditation in July 2026 and IDC care-coordination Leader recognition in September.
One less polished customer account is particularly instructive. In feedback published by ZeOmega, a director described a system evaluation after an optimization visit. Cost helped persuade the organization to stay with Jiva. So did a realization that its own support arrangements were siloed. The customer saw a chance to improve performance by changing how it supported the software.
The company’s U.S. careers page offers a glimpse of the people behind those tasks: hybrid work, continuing education, tuition reimbursement, and a paid community-service day. Its published team photographs include Diwali celebrations and yoga activities. They are modest details, but useful ones in a business whose product depends on translating between clinical teams, technical staff, and operations.
That is the transferable idea. Follow one request across departments. Count repeated questions, manual entries, and waiting time. Assign responsibility for the transitions, then test whether the new workflow closes them. ZeOmega’s case becomes compelling at that scale: one assessment shared, one request routed, one colleague able to pick up where another left off.